Piroxicam Solid Lipid Microparticles: In vitro and in vivo Evaluation
Published in June 2013 Issue 3 (Vol. 3, Issue 3, 2013)

Abstract
Authors (5)
NC Obitte
Department of Public Health, F...Department of Public Health, Federal University of...Department of Public Health, Federal University of Technology, Owerri,...Department of Public Health, Federal University of Technology, Owerri, Nigeria.
View all publications →SA Chime
Department of Public Health, F...Department of Public Health, Federal University of...Department of Public Health, Federal University of Technology, Owerri,...Department of Public Health, Federal University of Technology, Owerri, Nigeria.
View all publications →DC Ibe
Department of Public Health, F...Department of Public Health, Federal University of...Department of Public Health, Federal University of Technology, Owerri,...Department of Public Health, Federal University of Technology, Owerri, Nigeria.
View all publications →OR Nweke
Department of Public Health, F...Department of Public Health, Federal University of...Department of Public Health, Federal University of Technology, Owerri,...Department of Public Health, Federal University of Technology, Owerri, Nigeria.
View all publications →TC Ugwudah
Department of Public Health, F...Department of Public Health, Federal University of...Department of Public Health, Federal University of Technology, Owerri,...Department of Public Health, Federal University of Technology, Owerri, Nigeria.
View all publications →Download Article
Best for printing and citation
Download Article
Best for printing and citation
Article Information
Published in:
June 2013 Issue 3 (Vol. 3, Issue 3, 2013)- Article ID:
- AJPTR33023
- Paper ID:
- AJPTR-01-002061
- Published Date:
- 2013-06-01
Article Impact
How to Cite
Obitte & Chime & Ibe & Nweke & Ugwudah (2013). Piroxicam Solid Lipid Microparticles: In vitro and in vivo Evaluation. American Journal of PharmTech Research, 3(3), xx-xx. https://ajptr.scholarjms.com/articles/703
Article Actions
More from this Issue
Mucoadhesive Buccal Drug Delivery System- A Promising Alternative for Orally Poor Efficient Drugs
A Review on Mandookaparni
Virosomal Drug Delivery System: A Novel Vaccination Technology
More by These Authors
Formulation and evaluation of fixed dose combination of sustain release Glipizide and conventional release of Telmisartan drug bi-layered tablet with guggul as binding agent
2013 • Vol. 3, Issue 4
Read more →